Relationship Between the Lactate-to-Albumin Ratio and Acute Kidney Injury in Patients with Pulmonary Embolism: A Retrospective Cohort Study

Read full text
Authors: Doğan İliş, Ayça Arslan, İnanç Artaç, Muammer Karakayali, Ömer Kertmen, Hatice Taskan, Yüksel Erata, Ezgi Guzel, Yavuz Karabağ, İbrahim Rencüzoğulları
Cited by: 1
References: 51

Abstract

Background and Objectives: Pulmonary embolism (PE), the third most prevalent cause of cardiovascular death, is often regarded as a potentially fatal condition. Renal function has been shown to affect the short- and long-term prognosis of acute PE in several large registries. Therefore, the purpose of this study is to investigate the relationship between acute kidney injury (AKI) and the lactate-to-albumin ratio (LAR) in patients hospitalized for PE. Materials and Methods: 264 PE patients were included in this retrospective analysis. Based on the presence or absence of AKI, the study population was split into two groups. Results: Of the 264 patients included in our study, 161 (61%) were female. The median age was 67 ± 16 years. The sample was divided into two groups based on whether AKI developed (No AKI group, n = 176; AKI group, n = 88). A multivariate logistic regression analysis revealed that sPESI score, receiving fibrinolytic therapy (tPA), and LAR (OR: 6.334, 95% CI: 3.070–13.069; p < 0.001) were independently associated with AKI in patients with PE. In particular, an LAR > 0.55 predicted AKI in patients with PE, with a sensitivity of 75% and a specificity of 67% (AUC = 0.749, 95% CI = 0.692–0.800, p < 0.001). Conclusions: Our study demonstrates that the LAR independently predicts AKI in patients with PE. This is the first study that precisely examines this association in PE patients, as far as we are aware.

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Inflammatory Biomarkers in Disease Prognosis Acute Kidney Injury Research

Publication details

Journal / source
Medicina
Publisher
MDPI AG
Volume
62
Issue
3
Pages
474–474
Publication date
2 March 2026
Language
EN